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The selectivity of the antibiotic nystatin towards ergosterol compared to cholesterol is believed to be a crucial factor in its specificity for fungi.
In order to define the structural features of sterols that control this effect, nystatin interaction with ergosterol-, cholesterol-, brassicasterol- and 7-
dehydrocholesterol-containing palmitoyloleoylphosphocholine vesicles was studied by fluorescence spectroscopy. Variations in sterol structure
were correlated with their effect on nystatin photophysical and activity properties. Substitution of cholesterol by either 7-dehydrocholesterol or
brassicasterol enhance nystatin ability to dissipate a transmembrane K+ gradient, showing that the presence of additional double bonds in these
sterols–carbon C7 and C22, plus an additional methyl group on C-24, respectively–as compared to cholesterol, is fundamental for nystatin–sterol
interaction. However, both modifications of the cholesterol molecule, like in the fungal sterol ergosterol, are critical for the formation of very
compact nystatin oligomers in the lipid bilayer that present a long mean fluorescence lifetime and induce a very fast transmembrane dissipation.
These observations are relevant to the molecular mechanism underlying the high selectivity presented by nystatin towards fungal cells (with
ergosterol) as compared to mammalian cells (with cholesterol).
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Polyene macrolide antibiotics are a family of naturally
occurring compounds, mostly produced by Streptomyces
species, characterized by the presence of a large lactone ring
containing several double bonds [1]. AmB (an heptaene) and
nys (a tetraene linked to a diene) (Fig. 1) are the most important
members of this family because they are commonly used to treatAbbreviations: 7-DHC, 7-Dehydrocholesterol; AmB, Amphotericin B; bras,
brassicasterol; BrPC, 1-Palmitoyl-2-stearoyl (11–12)dibromo-sn-glycero-3-
phosphocholine; chol, cholesterol; erg, ergosterol; FCCP, (carbonyl cyanide p-
(trifluormethoxy)phenylhydrazone); LUV, large unilamellar vesicle; nys,
nystatin; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; Pyranine,
(8-hydroxypyrene-1,3,6-trisulfonic acid, trisodium salt); TMA-DPH, (1-(4-
trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene p-toluenesulfonate);
val, valinomycin
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doi:10.1016/j.bbamem.2006.03.008systemic and superficial fungal infections, respectively, despite
their important side effects [2].
The plasma membrane of the antibiotic-sensitive organisms
is the target for antifungal polyene drugs like nys, where they
form ion channels [1,3,4]. These channels disrupt membrane
function by causing uncontrolled cation transport through it that
eventually leads to cell death. The higher selectivity of these
antibiotics towards fungal cells compared to mammalian cells
has often been correlated with the type of sterol present in the
cell membrane, erg and chol (Fig. 1), respectively [5]. However,
the underlying molecular mechanism that controls the sterol
selectivity of these antibiotics is still controversial. Several
studies consider that sterols are an integral part of the aqueous
channels formed by the antibiotics [3,6], whereas others
proposed that chol only helps in the packing of the antibiotic
molecules by rigidifying the membrane [7]. Additionally, some
authors emphasize the absolute requirement for sterol presence
in order for transmembrane aqueous pores to be formed in the
lipid membranes [3,8], whereas others state the opposite [9–11].
Fig. 1. Chemical structures of the polyene antibiotic nystatin and of the sterols used in this study. Brassicasterol presents the ring system of cholesterol and the aliphatic
side chain of ergosterol and the reverse applies to 7-dehydrocholesterol.
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action might be distinct in erg- and chol- containing lipid
vesicles. In the first case, it was possible to monitor nys self-
assembly by following the increase in its mean fluorescence
lifetime, which was concomitant with the appearance of
transmembrane aqueous pores. These strongly fluorescent
species were not detected in POPC-only vesicles and chol-
containing liposomes.
The aim of this work was to clarify the mechanism of
action of nys, particularly to examine how the structural
modifications in sterols can influence nys-sterol interaction.
The sterols studied were chol, erg, 7-DHC and bras (Fig. 1).
These sterols all have a C5–C6 unsaturation on ring B.
Additionally, chol presents a C8 side chain, whereas erg bears
a methyl group on C-24. Erg also contains two extra
unsaturations on the C7–C8 bond on ring B and on the
C22–C23 bond of its aliphatic tail. In order to determine the
influence of the sterol ring structure versus side chain on the
spectroscopic and activity properties of nys, 7-DHC and bras
were chosen because their structure is a combination of chol
and erg, i.e., they have the ring system of one sterol with the
side chain of the other and vice-versa (Fig. 1). Furthermore, 7-
DHC is a biosynthetic precursor of chol and it has beensuggested that the polyene antibiotic AmB presents higher
affinity toward this sterol as compared to chol (e.g., [13]).
Accordingly to these findings, Feigin [14] has recently
reported on a new application of AmB related to cancer
therapy: the author has proposed a way to replace chol by its
precursor in hepatomas. Since the malignant hepatic cells are
not able to regulate chol biosynthesis, 7-DHC would
accumulate only in these cells. Due to the higher affinity of
AmB for this sterol, the antibiotic would interact preferentially
with the malignant cells, leading to their destruction.
Our results show that nys is able to permeabilize all type of
sterol-containing vesicles. However, the kinetics and the
structures formed are different: (i) in chol-containing vesicles
the initial rate of pore formation was very slow and higher nys
amounts were required to complete dissipate K+ gradient; (ii) in
the presence of both 7-DHC and bras, the kinetics and extent of
K+ efflux was increased, compared to chol; (iii) only erg was
able to induce the formation of strongly fluorescent antibiotic
aggregates together with an instantaneous gradient dissipation.
These findings imply that the presence of extra double bonds
either in the sterol ring (like 7-DHC) or side-chain (like bras)
promote the formation of nys channels, but the two features
(like in erg) are required for the formation of antibiotic-sterol
Table 1
Mole-fraction partition coefficients of nystatin, Kp, for vesicles with different
lipid composition (sterol-free and sterol-containing POPC LUV)
Sterol mol% Kp (×10
4)
Cholesterol 5 1.5±0.2
10 1.7±0.5
Brassicasterol 5 1.8±0.4
10 1.8±0.5
7-Dehydrocholesterol 5 1.9±0.3
10 1.9±0.7
Ergosterol 5 1.2±0.2
10 1.5±0.4
POPC-only vesicles – 1.4±0.2
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mean fluorescence lifetime.
2. Materials and methods
2.1. Materials
Nys, chol, and the ionophores valinomycin and FCCP were from Sigma (St.
Louis, MO). The phospholipids POPC and BrPC were obtained from Avanti
Polar Lipids (Alabaster, AL) and the sterols erg and 7-DHC were from Fluka
Chemika (Buchs, CH) whereas bras was purchased from Steraloids, Inc.
(Newport, RI).). Pyranine and TMA-DPH were from Molecular Probes
(Eugene, OR). All organic solvents were Uvasol grade from Merck.
2.2. Preparation of liposomes
POPC and sterol-containing POPC LUV with a mean diameter of 100 nm
were prepared by the extrusion method [15] as previously described [16]. The
resulting stock solutions were stored at 4 °C until used. The final phospholipid
concentration was determined by phosphate analysis [17].
2.3. Nys partitioning experiments
Partition coefficients of nys were determined by a centrifugation method
using brominated lipids [18]. The total and free nys concentrations were assayed
by absorption spectrophotometry using ε304=7.4×10
4 M−1 cm−1 [19].
The mole-fraction partition coefficient, Kp, of nys [20] was calculated and
used to compute the mean number of antibiotic molecules associated with a lipid
vesicle, <A>, [21]:
hAi ¼ lxi½N t½Lt
ð1Þ
where, μ is the average number of lipid molecules per lipid vesicle, and [N]t and
[L]t are the overall antibiotic and lipid concentration present in the sample.
2.4. Nys activity assays
H+/K+ exchange assays across the membrane bilayer were conducted as
described previously to indirectly evaluate the effect of nys on the potassium
permeability of the lipid vesicles [12]. Briefly, the decrease in the fluorescence
intensity of the entrapped pH sensitive pyranine was used to follow the
acidification of the intravesicular space of the liposomes prepared with a
variable lipid composition. The activity assays were started by submitting the
liposomes to a transmembrane K+ gradient of 3.3:1 [K+]in:[K
+]out. After 120 s,
nys (5–25 μM final concentration) was added to the lipid suspension. The
ionophore valinomycin was added to the liposomes after 300 s.
All the data were analyzed according to the formalism described in [12]. The
percentage of potassium gradient dissipation was calculated from:
%Kþdissipation ¼ pH
0
in  pH300in
pH0in  pHvalin
 
 100 ð2Þ
where pH0in and pH
300
in are the pH inside the lipid vesicles at times t=0 s and
t=300 s and pHvalin is the pH obtained after the addition of valinomycin.
The apparent initial rate of pore formation by nys in the liposomes, vo, was
determined from the initial slope of the function p′(t), which is the apparent
average number of pores per lipid vesicle that had been formed from t=0 to t
[22–24]:
p V tð Þ ¼ ln R tð Þ ¼ ln pHinðtÞ  pH
300
in
pH0in  pHvalin
 
ð3Þ
where R(t) is the retention function of the liposome population and pHin(t) is the
time course of the pH decrease of the inner vesicular space of the liposomes,
which is followed by the variation of fluorescence intensity of pyranine (see
Results).2.5. Absorption and fluorescence measurements
Absorption spectra were recorded at room temperature using a Jasco V-560
and steady-state fluorescence measurements were done in a SLM-Aminco 8100
Series 2 spectrofluorometer [16]. Nys and pyranine fluorescence measurements
were carried out with λexc=320 nm and λem=410 nm and λexc=460 nm and
λem=510 nm, respectively. Steady-state fluorescence anisotropy measurements
of TMA-DPH (λecx=355 nm and λem=428 nm) were obtained at a probe to
phospholipid molar ratio of 1:100.
The time-correlated single-photon timing method was used to obtain the
fluorescence intensity decays of nys. The instrumentation used and data analysis
was described in detail elsewhere [25]. The samples were excited at 320 nm and
the emission (at 410 nm) was detected at the magic-angle (54.7°) relative to the
vertically polarized excitation beam. The fluorescence intensity decay curves
were analyzed as a sum of exponential terms and the mean fluorescence lifetime
was calculated as:
hsi ¼
X
ais
2
i =
X
aisi ð4Þ
were αi and τi are the normalized amplitude and lifetime of component i.3. Results
3.1. Partition experiments
Lipid vesicles prepared with different sterols may influence
the partitioning behavior of the polyene antibiotic nys either
directly through the establishment of specific interactions
between the antibiotic and the sterols present in the membrane,
or indirectly by altering the bulk physical properties of the lipid
bilayer. In order to address this issue, the partitioning of nys
towards 5 and 10 mol% of the several sterols-containing lipid
vesicles was measured. It was found that the partition of nys into
the lipid vesicles was largely insensitive to the structure and
sterol content of the liposomes, always presenting a Kp value of
(1.7±0.2)×104 (n=8) (Table 1).
3.2. Nys self-association in the membranes
It has been previously shown that the main factor controlling
the fluorescence spectra and emission kinetics of nys is its
oligomeric state and packing in the membrane [19,21]. These
two properties were used here to monitor the formation of those
supramolecular aggregates by nys in 5 and 10 mol% bras- and
7-DHC containing POPC LUV. The excitation and emission
spectra of nys in lipid vesicles with 10 mol% of these sterols
Fig. 2. Normalized excitation (λem=410 nm) and emission (λexc=320 nm)
spectra of nystatin (20 μM) in the presence of (thick black) 10 mol% ergosterol-,
(thin black) brassicasterol- and (gray) 7-dehydrocholesterol-containing POPC
LUV.
Table 2
Effect of membrane sterol content on the steady-state fluorescence anisotropy of
nystatin, <r>nys (λexc=320 nm and λem=410 nm), and TMA-DPH, <r>TMA-DPH
(λexc=355 nm and λem=428 nm) in interaction with 1.4 mM sterol-containing
POPC LUV
Sterol mol% <r>nys (±0.01) <r>TMA-DPH (±0.001)
Cholesterol 10 0.28 –
Brassicasterol 5 0.28 0.194
10 0.29 0.198
7-Dehydrocholesterol 5 0.29 0.197
10 0.28 0.195
Ergosterol 10 0.30 –
The errors represent the standard deviation of 8 independent measurements
carried out with antibiotic concentrations between 0–25 μM and 3 independent
measurements carried out with antibiotic concentrations of 15, 20 and 25 μM for
TMA-DPH and nystatin fluorescence anisotropy measurements, respectively.
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lipid vesicles (Fig. 2). The emission spectra of the antibiotic
presented a single emission band centered at 404 nm, whereas
its excitation spectra exhibited the typical vibrational progres-
sion of the monomeric antibiotic molecule [21]. It was also
found that both the sterol content of the lipid vesicles (5 and 10
mol%) and the antibiotic overall concentration in solution
(between 2.5 and 25 μM) did not alter nys fluorescence spectra
in these conditions. On the other hand, nys behavior in 5 and 10
mol% erg-containing POPC LUV was different: its emission
spectra was blue-shifted with an emission maximum at 398 nm
and its excitation spectrum now presented a vibrational
progression typical of excitonic coupling [26]. In addition,
both spectra were dependent on the erg molar fraction and nys
concentration used, confirming that the nys-to-erg ratio in the
membranes influenced the interaction between the two
molecules, as previously shown [12]. Note that the transition
dipolar moments of the cromophores must be close and parallel
to each other in order to lead to excitonic coupling. Since
excitonic coupling was only observed when erg was present in
the vesicles, and was dependent both on sterol content and
antibiotic concentration, it clearly shows a specific antibiotic–
erg interaction.
Regarding nys photophysics, four-exponentials were always
required to describe the fluorescence intensity decay curves of
nys in interaction with sterol-containing liposomes. The best-
fitting parameters (pre-exponentials and lifetimes) were antibi-
otic-concentration independent for chol-, bras- and 7-DHC-
containing vesicles: nys presented two very fast (50–80 ps and
340–480 ps, respectively) and two slow (2.0–2.5 ns and 7.1–
7.4 ns, respectively) fluorescence lifetimes in these POPC/sterol
mixed bilayers, resulting in an intensity-weighted mean
fluorescence lifetime (Eq. (4)) of 5.0±0.3 ns. In contrast,
there was a sharp increase in nys mean fluorescence lifetime
from approximately 4 ns to 20 and 37 ns upon increasing the
antibiotic overall concentration in solution from 2.5 to 25 μM in
the presence of 5 and 10 mol% erg-containing POPC LUV,
respectively, in agreement with what was previously reportedfor this lipid vesicles [16]. The appearance of these long-lived
antibiotic fluorescent species has been formerly ascribed to nys
oligomerization in the membranes, which produces a strong
immobilization of its polyene chains and a concomitant
decrease of its non-radiative decay rates. These oligomers are
attributed to the transmembrane aqueous pores formed by nys
[12].
To further check for eventual changes undergone by the
aggregation state of nys partitioned into the lipid vesicles, the
steady-state fluorescence anisotropy of the antibiotic was also
measured in the presence of 5 and 10 mol% of the several sterol-
containing POPC LUV (Table 2). It was found that the
anisotropy of nys was essentially invariant and independent of
the type and sterol content of the lipid vesicles used for
antibiotic 15, 20 and 25 μM. From its high value in all the types
of vesicles (<r>=0.28±0.01), it can be concluded that the
antibiotic is, in all cases, strongly immobilized in the
membrane, and from this parameter, no specific information
on the interactions between nys and sterols is obtained.
Furthermore, the steady-state fluorescence anisotropy of
TMA-DPH, a fluorescent probe that is sensitive to surface
alterations in the membrane [27], also did not change with the
lipid vesicle composition within the antibiotic concentrations
used (<r>=0.196±0.002, Table 2). This is further evidencing
that membrane-induced alterations are localized and no long
range perturbations are occurring upon nys partition to the
membrane.
3.3. Nys activity assays
The polyene antibiotic nys interacts with the plasma
membrane of the antibiotic-sensitive organisms causing mono-
valent cation leakage [1]. Its effect on the permeability
properties of the lipid bilayers can be used to monitor the
formation of functional antibiotic species, which can be
correlated with spectroscopic changes undergone by the
antibiotic molecules. The variation of the fluorescence intensity
of the pyranine dye entrapped inside the lipid vesicles has been
used as a reliable spectroscopic method for measuring the
activity of this antibiotic. As shown in Fig. 3A, in all POPC/
sterol mixed bilayers, nys was able to induce a complete
Fig. 3. (A) Pyranine fluorescence intensity variation upon addition of nys to 10 mol% sterol-containing POPC lipid vesicles (see Materials and methods for further
details). Dependence of (B) the percentage of transmembrane K+ gradient dissipated 300 s after the beginning of each assay (before val addition), (C) the apparent
initial rate of pore formation, vo, and (D) the intensity-weighted mean fluorescence lifetime of the antibiotic, <τ>, on the mean number of membrane bound antibiotic
molecules per liposome, <A>. 10 mol% cholesterol- (ο), ergosterol- (•), brassicasterol- (▵) and 7-dehydrocholesterol- (□) containing POPC were used in these
experiments. The dashed vertical line at <A>=100 signals the onset of the sharp increase simultaneously detected in the initial rate of pore formation and in the mean
fluorescence lifetime of the antibiotic in the presence of 10 mol% erg-containing liposomes.
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addition of Val, an ionophore that is able to complete dissipate
the K+ gradient. The small variation observed on the gradient
after adding Val is only due to the effect of the solvent (see, e.g.,
[12]), showing that total gradient dissipation was already
attained. However, the kinetics of dissipation was dependent on
the type of sterol: whereas the addition of antibiotic to erg-
containing vesicles lead to an instantaneous and total efflux of
K+, total gradient dissipation was only achieved at higher time
in chol-containing vesicles. Substitution of chol by either 7-
DHC or bras increased in a similar way the rate of K+ efflux, but
was still slower compared to erg. In order to make a quantitative
comparison of nys activity in liposomes containing the different
sterols tested, the percentage of transmembrane K+ gradient
dissipated 300 s after the beginning of each assay (Eq. (2)) (Fig.
3B), the apparent initial rate of pore formation (Eq. (3)) (Fig.
3C), and the intensity-weighted mean fluorescence lifetime of
the antibiotic (Eq. (4)) (Fig. 3D), were plotted as a function of
the mean number of membrane bound antibiotic molecules per
liposome, <A>. Fig. 3 shows that: (i) membrane permeabiliza-
tion occurs in all type of vesicles with different kinetics, and (ii)the long-lived antibiotic species are formed only in the presence
of erg.
4. Discussion
The aim of this study was to investigate the influence of
sterol side chain and nucleus structure on nys binding to the
lipid vesicles and formation of active antibiotic species. In order
to understand what are the sterols structural features that
stabilize nys oligomers and increase their mean fluorescence
lifetime, we studied nys interaction with POPC liposomes
containing 5 and 10 mol% of bras and 7-DHC, which have the
side chain of erg and the sterol nucleus of chol and vice-versa,
respectively (Fig. 1), and in erg- and chol-containing lipid
vesicles.
The first issue addressed was the influence that sterols
exerted on nys partitioning to the lipid vesicles, since different
types of sterols might induce different bulk membrane
properties [28,29]. Chol and erg are known to order the
phospholipid acyl chains in the membrane leading to phase
separation [30,31] and sterols that similarly to erg also present
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shown to have an even higher ability to induce this effect
[29,32]. For the range of sterol concentration used in this study,
the bulk membrane properties of chol- and erg-containing lipid
vesicles were shown to be similar [30,31,33]. Nevertheless, it
was essential to determine the partition of nys to the different
sterol-loaded lipid vesicles, since specific interactions and not
the type of phase could be the ruling factor determining eventual
Kp variations. Our data showed that the partition of the polyene
antibiotic nys was insensitive to both the type of sterol and its
content on the lipid vesicles (5 and 10 mol%) (Table 1). It can
then be concluded that the surface antibiotic concentrations
reached in each type of lipid vesicles are very similar when the
experiments are carried out with the same total lipid
concentration in solution. Hence, the influence of this factor
on the final extent of nys oligomerization in the lipid vesicles
can be ruled out as a possible explanation for the variable
spectroscopic properties presented by the antibiotic. The same
applies regarding the observed differences in activity.
The fluorescence behavior of nys in the presence of bras- and
7-DHC POPC LUV was analogous to the one observed earlier
with chol-containing lipid vesicles [12,16], namely both its
excitation and emission spectra (Fig. 2) and its intensity-
weighted mean fluorescence lifetime were independent on
antibiotic concentration and sterol content. However, the
activity assays revealed that when in the presence of 7-DHC
and bras, nys was more efficient in dissipating the transmem-
brane potassium gradient (Fig. 3A, B and C): the initial rate of
pore formation and extent of gradient dissipation was increased
compared to chol/POPC mixed bilayers. These results raise
questions about the nature of the active species formed by the
antibiotic in each type of phospholipid vesicles. When in the
presence of chol-containing vesicles, nys was still able to
dissipate K+ gradient, but at a much slower rate. Even at high
antibiotic concentration, the initial rate of pore formation was
small, suggesting that in this situation initial membrane
permeabilization is occurring by a non-specific mechanism.
Nevertheless, comparing with vesicles lacking sterol in its
composition [12], ion efflux was higher showing that chol
accelerates the permeabilization process, as also reported for
AmB [34,35]. In fact, several studies using AmB suggest that,
independently of its aggregation state, this antibiotic is able to
permeabilize erg-containing lipid vesicles, but permeabilization
of chol-containing or sterol-free lipid vesicles occurred only
when in the aggregated or highly aggregated form, respectively
[11,36,37]. Moreover, it was also suggested [36] that in these
vesicles, AmB molecules would initially accumulated in the
surface or inside the membrane originating defects. Subsequent
association of antibiotic molecules within the membrane would
result in the enlargement of the pre-existing defects, ultimately
leading to pore formation. Regarding our data, is likely that a
similar mechanism is taking place in chol/POPC vesicles: low
nys concentration cause defects in the membrane which leads to
a moderate leakage of K+; at high antibiotic concentration, the
initial efflux of ions is still slow, but total gradient dissipation
occurs, suggesting that nys molecules are assembling. This is
further supported by recent results showing that in ternary chol/erg/POPC liposomes chol competes with erg for the binding to
nys and for antibiotic–sterol complex formation [33].
In the presence of erg, at all antibiotic concentrations
gradient dissipation is total, and the process of pore formation is
fast after a threshold nys concentration is reached. We proposed
[12] a two-stage model for membrane permeabilization by nys
in this type of vesicles. When the mean number of membrane-
bound nys molecules per lipid vesicle is low (<A>* < 100) the
antibiotic molecules transiently induce structural defects in the
membrane, perturbing its selective permeability. After reaching
this threshold, the classical model of transmembrane channel
formation occurs, leading to instantaneous and total gradient
dissipation. Note that the definition of <A> takes into account
both the nys molecules that are adsorbed and inserted into the
bilayer [21]. Identical antibiotic concentrations have similar
effects in the gradient dissipation at 300 s (Fig. 3B) when 7-
DHC and bras are present in the vesicles, but the initial rate of
pore formation is slower (Fig. 3C). The formation of very
compact and stable nys aggregates occurs only in the presence
of erg, suggesting a direct participation in the formation of
channel complex [7,35].
The fine details of the molecular arrangement adopted by the
antibiotic molecules in the aggregates formed vary consider-
ably, depending on the molecular structure of the sterol
incorporated in the membrane. Apparently, all the chemical
features that distinguish erg from chol, both in the ring and in
the tail, are essential requisites for the formation of strongly and
long-lived fluorescent oligomers by nys, presenting spectral
alterations typical of excitonic coupling. The formation of pores
with different sizes cannot be completely rule out, however, the
size of the aggregates should not interfere in the photophysical
properties of the antibiotic, since: (i) excitonic coupling can
only be attributed to the close proximity and parallel
arrangement between the transition moments of the chromo-
phores [26]; (ii) the long fluorescence lifetime is due to the
decrease of the non-radiative excited state deactivation upon the
increase of Nys rigidity. In addition, since nys partition is
independent both on sterol type and content, formation of more
pores in erg-containing vesicles is not a likely process. If the
sterol molecules facilitate the assembly of the channel by acting
as a “glue” that links the nys monomers together [38], then the
increased planarity, rigidity and polarizability of ring B with a
5,7-diene, as in erg and 7-DHC, is expected to promote a tighter
packing with the macrolide polyene antibiotic by an enhance-
ment of van der Waals forces, rigidifying the polyene chains.
Therefore, the non-radiative deactivation pathways of the
antibiotic decrease and, consequently, nys mean fluorescence
lifetime rises from around 5 to 37 ns. The importance of these
structural features of sterols for nys activity is supported by
experiments showing that nys toxicity was highly dependent on
the presence of sterols carrying a Δ5,7-dienic structure [39].
Other studies have also emphasized the importance of an extra
double bond in the sterol structure relatively to chol for an
increased strengthen of the hydrophobic interactions between
the polyene antibiotics and the sterols. However, there is no
consensus regarding its optimum positions: (i) some authors
point that an extra double bond in the carbon C7 of the ring
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importance (e.g., [13,37]), whereas others (ii) suggest that the
additional unsaturation should be present at the sterol side chain
in carbon C22, like in erg and bras [40,41]. The present study,
however, demonstrates that the appropriate conjugated system
of the sterol nucleus is not enough, and an adequate sterol tail is
also necessary to stabilize nys oligomers because 7-DHC,
which lacks a methyl group at position 24 but has a double bond
configuration of the B ring identical to that of erg, failed to
induce the formation of long-lived fluorescent antibiotic
aggregates. The simultaneous introduction of a double bond
at position 22 and the addition of an alkyl group at position 24
make the sterol side chain of erg bulkier and stiffer,
characteristics that seem to help to stabilize the interaction
between nys and the sterol. Therefore, the sterol–antibiotic
complexes formed are very compact, and also putatively more
stable [6,8]. However, regarding the activity of nys, it should be
stressed that the single introduction of alterations either in the
ring or in the tail increases the antibiotic ability to permeabilize
the membranes showing that they are essential for nys-sterol
interaction. In addition, it was clearly shown in the present study
that 7-DHC-containing liposomes present higher sensitivity to
the antibiotic action, as compared to chol-rich vesicles, which
makes 7-DHC suitable for replacing chol in hepatomas, as
suggested by Feigin [14], for a new application of polyene
antibiotics in cancer therapy.
Our findings provide an example of how slight structural
alterations of sterols can affect the architecture of the channel
structures formed by nys, which in turn must be responsible for
its antifungal action and drug toxicity in mammalian cells.
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